Literature DB >> 6368885

Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.

L S Goodman, M M Wintrobe, W Dameshek, M J Goodman, A Gilman, M T McLennan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368885     DOI: 10.1001/jama.251.17.2255

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  25 in total

1.  Two hundred years of cancer research.

Authors:  Vincent T DeVita; Steven A Rosenberg
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

Review 2.  Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

Authors:  Sophie Marchal; Amélie El Hor; Marie Millard; Véronique Gillon; Lina Bezdetnaya
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

3.  DNA crosslinking damage and cancer - a tale of friend and foe.

Authors:  Yaling Huang; Lei Li
Journal:  Transl Cancer Res       Date:  2013-06       Impact factor: 1.241

4.  Maxwell Myer Wintrobe: new history and a new appreciation.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2007

Review 5.  Understanding resistance to combination chemotherapy.

Authors:  Justin R Pritchard; Douglas A Lauffenburger; Michael T Hemann
Journal:  Drug Resist Updat       Date:  2012-11-17       Impact factor: 18.500

Review 6.  Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.

Authors:  Sonia Tusell Wennier; Jia Liu; Grant McFadden
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

Review 7.  Biology-driven cancer drug development: back to the future.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  BMC Biol       Date:  2010-04-12       Impact factor: 7.431

8.  Chemotherapy for early-stage breast cancer: a brief history.

Authors:  M Verrill
Journal:  Br J Cancer       Date:  2009-09       Impact factor: 7.640

Review 9.  Why Great Mitotic Inhibitors Make Poor Cancer Drugs.

Authors:  Victoria C Yan; Hannah E Butterfield; Anton H Poral; Matthew J Yan; Kristine L Yang; Cong-Dat Pham; Florian L Muller
Journal:  Trends Cancer       Date:  2020-06-11

10.  Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.

Authors:  Alexandre Barbault; Frederico P Costa; Brad Bottger; Reginald F Munden; Fin Bomholt; Niels Kuster; Boris Pasche
Journal:  J Exp Clin Cancer Res       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.